Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Jan 31;10(1):114-25.
doi: 10.3390/10010114.

Covalent polymer-drug conjugates

Carlos Elvira  1 , Alberto Gallardo, Julio San Roman, Alejandro Cifuentes
Affiliations
Review

Covalent polymer-drug conjugates

Carlos Elvira et al. Molecules. .

Abstract

In this work, polymer-drugs conjugates used as drug delivery systems (DDS) are revised attending to their chemical conjugation. Namely, the classification of this type of DDS is based on the conjugation sites of the reactive groups (i.e., via end groups or pendant polymer groups). Advantages and limitations of these types of DDS are discussed through representative examples of polymer-drugs and polymer-proteins conjugates recently developed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Ringsdorf model of synthetic polymer drugs.
Figure 2
Figure 2
Biodegradable bonds used to conjugate bioactive molecules to polymer backbones.
Figure 3
Figure 3
Typical end-group polymer-drug conjugate based on polyethylene glycol (PEG) modifications.
Figure 4
Figure 4
Chemical structure of SMANCS conjugates.
Figure 5
Figure 5
Chemical structure of HPMA copolymer-drug conjugate. X = peptide link, D = drug.
Figure 6
Figure 6
- Drug release at pH = 7.4 as (mg drug)/(g device) as a function of the time for all the copolymeric systems of 2-hydroxyethyl methacrylate, HEMA, and a methacrylamide that incorporates ibuprofen: N-{4-[2-(4-isobutylphenyl) propionyloxy] phenyl} methacrylamide, MAI. The weight compositions of the systems are 1 (○), 2.5 (□), 5 (Δ), 10 (formula image), 20 (formula image) and 30 % (formula image).
See this image and copyright information in PMC

References

    1. Mathiowitz E. Encyclopedia of Controlled Drug Delivery. Wiley-Interscience; New York: 1999.
    1. Kydonieus A. Treatise on Controlled Drug Delivery. Marcel Dekker; New York: 1992.
    1. Baker R. Controlled Release of Biologically Active Agents. Academic Press; New York: 1987.
    1. Shiino D., Murata Y., Kataoka K., Koyama Y., Yokoyama M., Okano T., Sakurai Y. Preparation and characterization of a glucose-responsive insulin-releasing polymer device. Biomaterials. 1994;15:121–128. - PubMed
    1. Bromberg L.E., Ron E.S. Temperature-responsive gels and thermogelling polymer matrices for protein and peptide delivery. Adv. Drug Deliv. Rev. 1998;31:197–221. - PubMed

MeSH terms